Ultragenyx Pharmaceutical Inc.
RARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001515673
In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Ultragenyx Pharmaceutical Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 302
- +30 vs. Q2 2024
- Shares held
- 86.9M
- +4.30M (+5.2%) vs. Q2 2024
- Total value
- $4.83B
- +$1.43B (+42.1%) vs. Q2 2024
- New holders
- 59
- 111 more added
- Sold out
- 29
- 92 more reduced
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 311 | $3.55B |
| Q1 2026 | 298 | $2.05B |
| Q4 2025 | 288 | $2.16B |
| Q3 2025 | 303 | $2.87B |
| Q2 2025 | 311 | $3.42B |
| Q1 2025 | 301 | $3.25B |
| Q4 2024 | 314 | $3.68B |
| Q3 2024 | 302 | $4.83B |
| Q2 2024 | 275 | $3.63B |
| Q1 2024 | 270 | $3.73B |
| Q4 2023 | 237 | $3.84B |
| Q3 2023 | 221 | $2.52B |
| Q2 2023 | 243 | $3.21B |
| Q1 2023 | 230 | $2.76B |
| Q4 2022 | 228 | $3.15B |
| Q3 2022 | 233 | $2.81B |
| Q2 2022 | 225 | $4.03B |
| Q1 2022 | 240 | $4.87B |
| Q4 2021 | 235 | $5.69B |
| Q3 2021 | 223 | $6.01B |
| Q2 2021 | 242 | $6.24B |
| Q1 2021 | 255 | $7.73B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Ultragenyx Pharmaceutical Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,828,848 | $323.8M | 0.01% | +5,828,848 | New |
| Vanguard Group Inc | 9,945,473 | $552.5M | 0.01% | +164,980+1.7% | Added |
| Proequities, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −33,868−100.0% | Sold out |
| Clearline Capital LP | 0 | $0 | 0.00% | −32,961−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −30,651−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Eisler Capital (US) LLC | 0 | $0 | 0.00% | −19,907−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −18,585−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −14,236−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −10,250−100.0% | Sold out |
| Pearl River Capital, LLC | 0 | $0 | 0.00% | −7,671−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −7,147−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −6,137−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −2,531−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −718−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −168−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |
| JJJ Advisors Inc. | – | – | – | – | Not filed |